Trisomy of chromosome 21 clearly predisposes the development of GATA1 mutations in utero [54], but little is known regarding risk factors for the development of ML-DS in a subset of individuals with transient leukemia. The gene discussed is GATA1; the disease is transient myeloproliferative syndrome.